Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verita Neuro is a global leader in neurological restoration and regenerative medicine, specializing in advanced treatments for spinal cord injuries, stroke, and traumatic brain injuries. Founded in 2015 as part of the Verita Healthcare Group, the company pioneered the use of Epidural Stimulation outside of clinical trials and has since expanded its portfolio to include BrainStim (motor cortex stimulation), LamiSpine, and integrated stem cell therapies. Verita Neuro operates international treatment centers in Thailand and Mexico, with partnerships in Canada and the UAE, providing a comprehensive "end-to-end" recovery model that combines surgical intervention with intensive, personalized neuro-rehabilitation. The company is currently integrating artificial intelligence to optimize stimulation mapping and has partnered with Lifeward to incorporate robotic exoskeletons into its rehabilitation protocols.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verita Neuro.